Immune-Based Drug Shows Potential Against Another Form of Lung Cancer
Patients with squamous cell non-small cell lung cancer who got nivolumab lived longer, had fewer side effects
Source: HealthDay
Related MedlinePlus Pages: Lung Cancer, Medicines via MedlinePlus Health News Read More Here.. Lake forest health and fitness http://ift.tt/1ENRDbl
No comments:
Post a Comment